Cases & Deals

AbbVie acquires Mavupharma

Clients AbbVie Inc.

Jones Day advised AbbVie Inc. in its acquisition of Seattle-based Mavupharma, a privately held biopharmaceutical company focused on novel approaches to target the STING (STimulator of INterferon Genes) pathway for the treatment of cancer.